Distinguished in Crohn's Disease

Daniel R. Gaya

Glasgow Royal Infirmary
Glasgow, SCT, GB 
Distinguished in Crohn's Disease
Glasgow Royal Infirmary
Glasgow, SCT, GB 
OverviewLocationsClinical Research

Overview

Daniel Gaya practices in Glasgow, United Kingdom. Mr. Gaya is rated as a Distinguished expert by MediFind in the treatment of Crohn's Disease. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Colitis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 30 articles and participated in 2 clinical trials in the study of Crohn's Disease.

Gender
Male

Locations

Glasgow Royal Infirmary
Glasgow, SCT G40SF, United Kingdom
Other Locations
Guy's and St Thomas' NHS Foundation Trust
London, ENG, United Kingdom
Aberdeen Royal Infirmary
Aberdeen, SCT, United Kingdom
St Mark's Hospital, London North West Healthcare NHS Trust
Harrow, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
The PRognostic Effect of Environmental Factors in Crohn's and Colitis
The PRognostic Effect of Environmental Factors in Crohn's and Colitis
Enrollment Status: Completed
Publish Date: May 20, 2024
View 1 Less Clinical Trial

66 Total Publications

Inter- and Intraobserver Variability in Bowel Preparation Scoring for Colon Capsule Endoscopy: Impact of AI-Assisted Assessment Feasibility Study.
Inter- and Intraobserver Variability in Bowel Preparation Scoring for Colon Capsule Endoscopy: Impact of AI-Assisted Assessment Feasibility Study.
Journal: Cancers
Published: July 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gaya's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile